The Biomarker Discovery Program is a multidisciplinary team that includes oncologists, surgeons, pathologists, molecular biologists, bioengineers, bioinformaticians and others. By combining expertise, the program takes a clinical question, and answers it through a four-phase approach: Discovery, experimental validation, preclinical validation and clinical validation.
The Co-Directors answer the following three questions in this video:
- How do you identify a Biomarker?
- What projects are you currently working on?
- What are some challenges you face?
Discover the latest in Biomarkers, and Genomics, at our annual Individualizing Medicine Conferencethis year, October 6-8!